"Remember, no one ever died of a skinny buttocks." -- Arthur Perry, MD, of Lenox Hill Hospital in New York, on the risk-benefit ratio of Brazilian butt lift surgery.
"I get up every morning and I look at patient messages and half of them are due to Mounjaro." -- Karl Nadolsky, DO, of Holland Hospital in Michigan, on the shortage of the diabetes drug tirzepatide.
"There is very frightening language in the decision indicating where the court might be inclined to go." -- Jennifer Dalven, JD, director of the ACLU Reproductive Freedom Project, discussing an appeals court ruling on mifepristone (Mifeprex).
"If you're using an AI program to direct patients to hospital parking, a little bit of inaccuracy is not life-threatening. It may be frustrating, but there are no fatalities." -- David Asch, MD, MBA, of the University of Pennsylvania Perelman School of Medicine in Philadelphia, on AI applications in medicine.
"Just because something is or considered safe orally, does not mean it would be safe if inhaled." -- Kambez Benam, DPhil, of the University of Pittsburgh, discussing menthol-flavored vapes.
"My message to [the incoming residents] was, 'Don't let anyone take your joy. You absolutely earned it, and we're going to do absolutely everything to support you'." -- David Spain, MD, director of Stanford's general surgery residency program, reacting to comments directed at the incoming all-female cohort.
"Would this have happened to a disorder predominantly of men?" -- Laura McWhirter, MBChB, PhD, of the University of Edinburgh in Scotland, discussing stigma attached to functional neurological disorder.
"I guess everyone was waiting for this study to see if recommendations would change." -- Luis Pacheco, MD, of the University of Texas Medical Branch in Galveston, about prophylactic tranexamic acid during cesarean delivery.